Rights Issue Dilution for Shareholders

A rights issue is a capital raise in which a company offers its existing shareholders the right (but not the obligation) to buy new shares at a fixed discount to the market price. Shareholders who exercise their rights purchase the discounted shares and dilute non-participating shareholders. The non-participants lose equity stake, voting power, and per-share earnings, even though the company’s total profits may not change. Understanding the mechanics of rights issue dilution—and how to calculate the theoretical ex-rights price—is essential for deciding whether to exercise one’s rights.

How a rights issue dilutes non-participating shareholders

Imagine a company with 100 million shares outstanding trading at USD 10 per share (market cap USD 1 billion). It announces a 1-for-10 rights issue at USD 8 per share, allowing each shareholder to buy one new share for every 10 held. This raises USD 80 million (10 million new shares × USD 8).

A shareholder with 1,000 shares can buy 100 more at USD 8, investing USD 800. If the shareholder exercises, they own 1,100 of the 110 million total shares (0.909% vs. the original 1.0%). Their ownership percentage has declined. More notably, if the company’s profits remain flat at USD 50 million, earnings per share drops from USD 0.50 to USD 0.45 (USD 50M / 110M). The shareholder has the same economic claim on company profits but now split across more shares.

A shareholder who does not exercise keeps 1,000 of the 110 million shares (0.909%), a larger absolute loss of stake. Their share count is unchanged, but the company’s equity has grown. Their voting power and claim on dividends have been diluted.

The ex-rights date and split

Rights issues create a brief period of complexity around the ex-rights date. Before the ex-date, shares trade “cum-rights”—the buyer also receives the rights. After the ex-date, shares trade “ex-rights” and rights trade separately. A shareholder who sells shares before the ex-date forfeits the rights; if they sell after, they keep the rights and can still exercise.

This split allows a secondary market for rights to develop. If a shareholder does not want to invest more money, they can sell their rights to another investor. This provides optionality but also creates price relationships that must be reconciled (see below).

Calculating the theoretical ex-rights price

The theoretical ex-rights price is the price at which the stock should trade once the rights are detached, assuming all participants act rationally and the company’s value is unchanged.

Formula:

TERP = (Current Price × Old Shares + Subscription Price × New Shares) / (Old Shares + New Shares)

Worked example:

• Current stock price: USD 10
• Old shares: 100 million
• Subscription price: USD 8
• Rights ratio: 1-for-10 (so new shares = 10 million)

TERP = (USD 10 × 100M + USD 8 × 10M) / (100M + 10M) = (USD 1,000M + USD 80M) / 110M = USD 9.82

The stock should trade around USD 9.82 ex-rights. A shareholder who holds through the ex-date without exercising will see their stock price drop from USD 10 to USD 9.82, an immediate 1.8% loss. However, they can often sell their rights; the rights should be worth approximately USD 0.18 per share of ownership (the difference between USD 10 and USD 9.82), allowing them to partially offset that loss.

In a frictionless market, a shareholder is indifferent between exercising, selling rights, or doing nothing—the net outcome is the same. In reality, transaction costs, taxes, and market timing create small variations.

Why shareholders face a decision

The rights issue creates a dilemma for those who do not exercise:

1. Hold and dilute: Do nothing, keep the same share count, but watch ownership percentage and per-share earnings decline. If the stock price stays at TERP, the total value of holdings falls.

2. Exercise: Invest additional capital at the discounted rate. This requires liquidity and conviction in the company. If the company deploys capital well, the investment pays off; if not, the shareholder has added to a losing position.

3. Sell rights: Avoid new capital injection but realize cash from the right. If the stock rises significantly after the offer, selling rights gives up upside participation.

4. Buy in open market: Do not exercise rights but purchase shares in the secondary market if they fall in price. This delays decision-making and incurs risks if the stock rallies.

Why companies issue rights

Companies use rights issues to raise capital while offering existing shareholders first refusal. This is common in jurisdictions where rights protection is strong (Europe, Australia, India) and less common in the US.

Rights issues are particularly attractive when a company wants to avoid diluting outside shareholders beyond a certain threshold or when raising capital from a thinly traded stock is difficult. The discount—typically 10–20% below the trading price—compensates shareholders for the dilution and makes the offer more enticing than a public offering at market price.

A financially troubled company might issue rights at a steep discount as a last-resort capital raise; a healthy company might issue rights at a modest discount as part of a planned capital structure adjustment.

Dilution in practice

The dilution experienced by non-participants is permanent if the new capital does not generate proportional returns. If the company raises USD 80 million and invests it in projects earning 5% annually (USD 4 million), then total earnings rise from USD 50M to USD 54M. Per-share earnings on 110M shares is USD 0.491, a modest gain. But if the capital earns only 2% (USD 1.6M), earnings per share is actually USD 0.468, worse than before.

The key metric is return on new capital. If new projects earn the company’s cost of capital (say, 10%), the firm’s overall value is preserved and dilution is mechanical (ownership %) but economically neutral. If new projects earn above that hurdle, dilution is offset by profit growth.

Conversely, a company that raises capital and earns below its cost of capital destroys shareholder value; dilution becomes economically real.

Rights trading and pricing

Rights can be traded on stock exchanges during the exercise period. The price of a right is theoretically (and approximately in practice):

Right Value ≈ (Stock Price − Subscription Price) / (1 + Rights Ratio Denominator)

Using the USD 10 / USD 8 / 1-for-10 example: Right Value ≈ (USD 10 − USD 8) / 11 = USD 0.18.

A shareholder can sell the right for roughly USD 0.18 instead of exercising. If they hold the stock, the ex-date price will drop to approximately USD 9.82, and the total position value (stock + cash from selling rights) is preserved. This flexibility is valuable for investors who lack liquidity or want to avoid the decision.

International prevalence

Rights issues are much more common outside the US. In the UK, Australia, Canada, and continental Europe, rights are a standard capital-raising tool, and shareholders expect them. In the US, companies more often raise capital through secondary offerings or shelf registrations, which dilute all shareholders equally but do not grant preferential purchase rights.

Some countries mandate or strongly encourage rights issues for publicly listed companies, treating shareholder preemption as a fundamental right. Others allow companies to issue new shares without offering rights first.

Contingency and underwriting

Many rights offers are “underwritten”—an underwriter commits to buy any unexercised rights at a guaranteed price, eliminating the company’s risk that the capital raise will fail. This underwriting fee is typically 1–3% of the capital raised. Ununderwritten rights are rarer and carry more risk for the issuer.

See also